Found: 28
Select item for more details and to access through your institution.
Labeling Changes and Costs for Clinical Trials Performed Under the US Food and Drug Administration Pediatric Exclusivity Extension, 2007 to 2012.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Determinants of Market Exclusivity for Prescription Drugs in the United States.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Physicians and Insider Trading.
- Published in:
- 2015
- By:
- Publication type:
- journal article
EACH Person's Right: The Importance of Federal Abortion Care Funding to Health Care Reform.
- Published in:
- American Journal of Law & Medicine, 2022, v. 48, n. 2/3, p. 266, doi. 10.1017/amj.2022.25
- By:
- Publication type:
- Article
Expansion of the Priority Review Voucher Program Under the 21<sup>st</sup> Century Cures Act: Implications for Innovation and Public Health.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Perils of Panic: Ebola, HIV, and the Intersection of Global Health and Law.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Differences in Diabetic Prescription Drug Utilization and Costs Among Patients With Diabetes Enrolled in Colorado Marketplace and Medicaid Plans, 2014-2015.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 1, p. e2140371, doi. 10.1001/jamanetworkopen.2021.40371
- By:
- Publication type:
- Article
The Alabama Embryo Decision—The Politics and Reality of Recognizing "Extrauterine Children".
- Published in:
- JAMA: Journal of the American Medical Association, 2024, p. 1083, doi. 10.1001/jama.2024.3559
- By:
- Publication type:
- Article
E-Cigarettes and FDA Nicotine Cap—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 4, p. 359, doi. 10.1001/jama.2023.24524
- By:
- Publication type:
- Article
Including E-Cigarettes in the FDA Rule Limiting Nicotine.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 12, p. 1129, doi. 10.1001/jama.2023.14254
- By:
- Publication type:
- Article
Court Intrusion Into Science and Medicine—The Mifepristone Decisions.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 20, p. 1735, doi. 10.1001/jama.2023.7790
- By:
- Publication type:
- Article
Personal Protective Equipment for COVID-19: Distributed Fabrication and Additive Manufacturing.
- Published in:
- American Journal of Public Health, 2020, v. 110, n. 8, p. 1162, doi. 10.2105/AJPH.2020.305753
- By:
- Publication type:
- Article
Neither Ethical Nor Effective: The False Promise of Involuntary Commitment to Address the Overdose Crisis.
- Published in:
- Journal of Law, Medicine & Ethics, 2020, v. 48, n. 4, p. 741, doi. 10.1177/1073110520979384
- By:
- Publication type:
- Article
Letter to the Editor.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
The Tax Cuts and Jobs Act of 2017 and the Pharmaceutical Industry.
- Published in:
- Journal of Law, Medicine & Ethics, 2018, v. 46, n. 3, p. 806, doi. 10.1177/1073110518804246
- By:
- Publication type:
- Article
PUBLIC HEALTH PRODUCT HOPS.
- Published in:
- American University Law Review, 2023, v. 73, n. 2, p. 395
- By:
- Publication type:
- Article
Analysis of SteraMist ionized hydrogen peroxide technology in the sterilization of N95 respirators and other PPE.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-81365-7
- By:
- Publication type:
- Article
REPRODUCTIVE RIGHTS AND MEDICO-LEGAL EDUCATION POST-DOBBS: A FIRESIDE CHAT.
- Published in:
- Journal of Health Law & Policy, 2024, v. 17, n. 2, p. 221
- By:
- Publication type:
- Article
Patient Assistance Programs and the Anti-Kickback Statute: Charting a Pathway Forward.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry.
- Published in:
- 2018
- By:
- Publication type:
- journal article
FDA and EMA Biosimilar Approvals.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Micro-inequities in Medicine.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
The Opioid Epidemic: Fixing a Broken Pharmaceutical Market.
- Published in:
- Harvard Law & Policy Review, 2017, v. 11, n. 2, p. 463
- By:
- Publication type:
- Article
Assessing the filtration efficiency and regulatory status of N95s and nontraditional filtering face-piece respirators available during the COVID-19 pandemic.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The next forum for unraveling FDA off-label marketing rules: State and federal legislatures.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
The Wrong Cure: Financial Incentives for Unimpressive New Antibiotics.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem.
- Published in:
- 2019
- By:
- Publication type:
- journal article
PHARMACEUTICAL POLICY IN THE UNITED STATES IN 2019: AN OVERVIEW OF THE LANDSCAPE AND AVENUES FOR IMPROVEMENT.
- Published in:
- Stanford Law & Policy Review, 2019, v. 30, n. 2, p. 421
- By:
- Publication type:
- Article